Pages that link to "Q46450693"

The following pages link to 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats (Q46450693):

Displaying 42 items.

• Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review (Q24602117) (← links)
• Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats (Q24602751) (← links)
• 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease (Q28287100) (← links)
• Increased expression of 5-HT6 receptors in the rat dorsomedial striatum impairs instrumental learning (Q28566415) (← links)
• Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History. (Q30373383) (← links)
• Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats (Q30444469) (← links)
• Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. (Q30486338) (← links)
• Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia (Q30489404) (← links)
• A cognitive deficit induced in rats by chronic intermittent cold stress is reversed by chronic antidepressant treatment (Q34077083) (← links)
• E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. (Q34111024) (← links)
• Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. (Q34283319) (← links)
• Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation (Q34618354) (← links)
• Pharmacological enhancement of memory and executive functioning in laboratory animals. (Q34661221) (← links)
• Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex (Q34699454) (← links)
• Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task (Q34847404) (← links)
• Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms (Q35009210) (← links)
• Alzheimer's disease and age-related memory decline (preclinical) (Q35041190) (← links)
• 5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms (Q36346938) (← links)
• Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching (Q36540788) (← links)
• The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats (Q36797180) (← links)
• Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration (Q37081349) (← links)
• Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats (Q37081388) (← links)
• Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment (Q37354597) (← links)
• Asenapine effects in animal models of psychosis and cognitive function (Q37370296) (← links)
• Emerging role of sertindole in the management of schizophrenia (Q42427678) (← links)
• Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific. (Q43188186) (← links)
• Activation of 5-HT(6) receptors facilitates attentional set shifting (Q43245177) (← links)
• Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat. (Q46067102) (← links)
• Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms (Q46130784) (← links)
• Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions (Q46313880) (← links)
• Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting (Q46597031) (← links)
• Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study (Q46661372) (← links)
• Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics. (Q46840298) (← links)
• A null mutation of the serotonin 6 receptor alters acute responses to ethanol (Q46848285) (← links)
• Attention switching after dietary brain 5-HT challenge in high impulsive subjects (Q48118813) (← links)
• Lesions of the ventral midline thalamus produce deficits in reversal learning and attention on an odor texture set shifting task (Q48560403) (← links)
• (+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics (Q48587659) (← links)
• Low-dose prazosin in combination with 5-HT6 antagonist PRX-07034 has antipsychotic effects (Q50621504) (← links)
• Evidence that the attentional set shifting test in rats can be applied in repeated testing paradigms (Q50666227) (← links)
• Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics. (Q51976441) (← links)
• Prenatal Protein Malnutrition Leads to Hemispheric Differences in the Extracellular Concentrations of Norepinephrine, Dopamine and Serotonin in the Medial Prefrontal Cortex of Adult Rats (Q64062517) (← links)
• Improved visual discrimination learning in mice with partial 5-HT2B gene deletion (Q99399921) (← links)